Cytoplasmic cytokines in lymphoproliferative disorders: Multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia

Citation
K. Ohshima et al., Cytoplasmic cytokines in lymphoproliferative disorders: Multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia, LEUK LYMPH, 38(5-6), 2000, pp. 541-545
Citations number
16
Categorie Soggetti
Hematology,"Onconogenesis & Cancer Research
Journal title
LEUKEMIA & LYMPHOMA
ISSN journal
10428194 → ACNP
Volume
38
Issue
5-6
Year of publication
2000
Pages
541 - 545
Database
ISI
SICI code
1042-8194(200008)38:5-6<541:CCILDM>2.0.ZU;2-H
Abstract
Cytokines play an important role in the pathogenesis of lymphomas via autoc rine or paracrine mechanisms, or both. Here we determined the proportion of CD3-positive T lymphocytes containing various types of cytokines in enlarg ed lymph nodes. Lymph nodes were obtained from 16 patients with various lym phoproliferative disorders, including 3 cases with angioimmunoblastic lymph adenopathy with dysproteinemia (AILD), 3 cases with adult T cell leukemia/l ymphoma (ATLL), 2 cases with T-cell nonspecific malignant lymphoma (T-ML), 3 cases with B-cell diffuse large malignant lymphoma (BDL), 3 cases with hi stiocytic necrotizing lymphadenitis (HNL), and 2 cases with non-specific ly mphadenitis (NSL), The percentages of T lymphocytes positive for cytoplasmi c cytokines IL-2, IL-4, IL-5, IL-6, IL-13, TNF-alpha, and INF-gamma were de termined. The percentage of INF-gamma positive T lymphocytes was high in re active lymphadenopathy of NSL and HNL. AILD showed a high proportion of TNF -alpha positive T-lymphocytes, and in addition, the percentages of IL-2, IL -4, IL-5, IL-6, IL-13 and INF-gamma positive T-lymphocytes were relatively higher than in other diseases. Our results supported the state of multiple hypercytokinemia typically seen in AILD and suggested that the source of th e cytokines is the lymph nodes. Our results also suggested that multiple cy tokine networks play an important role in the clinical and histopathologica l features of AILD. Modulation of the cytokine network may be the logical o bjective in future therapeutic strategies designed for AILD.